Patent details

Herbas

VPB

Print

EN | LT

LT - USE OF DNASE TO IMPROVE SAFETY AND EFFICACY OF ANTI-CANCER CHEMOTHERAPY

EN - USE OF DNASE TO IMPROVE SAFETY AND EFFICACY OF ANTI-CANCER CHEMOTHERAPY

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 38/46
		A61K 45/06
		A61P 35/00
		A61P 43/00
		A61K 31/704
		A61K 31/513
		A61K 31/675
		A61K 31/7068
		A61K 31/7048

European patent
(11)	Number of the document	3368064
(13)	Kind of document	T
(96)	European patent application number	15907392.3
	Date of filing the European patent application	2015-10-29
(97)	Date of publication of the European application	2018-09-05
(45)	Date of publication and mention of the grant of the patent	2021-05-19
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/RU2015/000721
	Date	2015-10-29

PCT application publication
(87)	Number	WO 2017/074211
	Date	2017-05-04

Inventors
(72)	GENKIN, Dmitry Dmitrievich, RU TETS, Georgy Viktorovich, RU TETS, Viktor Veniaminovich, RU

Grantee
(73)	CLS Therapeutics Limited, Frances House, Sir William Place St. Peter Port, Guernsey, Channel Islands, GY1 1GX, GG

Title
(54)	USE OF DNASE TO IMPROVE SAFETY AND EFFICACY OF ANTI-CANCER CHEMOTHERAPY
	USE OF DNASE TO IMPROVE SAFETY AND EFFICACY OF ANTI-CANCER CHEMOTHERAPY